April WKW Frontiers in Neuroscience Speaker: Dr. Manpreet K. Singh

Manpreet K. Singh, MD, MS - April 20, 2021

"Evolving Neuroscience-Informed Interventions for Pediatric-Onset Mood Disorders"

William K. Warren, Jr.  Frontiers in Neuroscience Lecture 
Virtual Presentation via Zoom 
12:00 pm - 1:00 pm     Program

Zoom Link:
Join Zoom Meeting
https://zoom.us/j/95301637203

Meeting ID: 953 0163 7203
Passcode: 083713

Dr. Singh is Associate Professor of Psychiatry and Behavioral Sciences, and leads a program aimed to accelerate understanding and treatment in youth with or at high risk for developing a major mood disorder.
 
Dr. Singh earned her MD at Michigan State University and her MS at University of Michigan.  She completed her combined residency training in Pediatrics, Psychiatry, and Child and Adolescent Psychiatry at Cincinnati Children’s Hospital Medical Center. After two years of T32 postdoctoral training at Stanford’s Center for Interdisciplinary Brain Sciences Research, she joined the faculty at Stanford in 2009. 
 
Dr. Singh leads a multidisciplinary team that evaluates and treats youth with a spectrum of mood disorders as young as age 2 and well into their 20s. Her NIMH and industry funded studies examine mechanisms underlying mood disorders and apply cutting edge strategies to directly modulate the brain using transcranial magnetic stimulation and real time neurofeedback.  She is also investigating the efficacy and safety of pharmacotherapies and psychotherapies for youth with and at risk for bipolar disorder, such as family focused psychotherapy and mindfulness meditation, to reduce mood symptoms and family stress.  All of these areas of research aim to elucidate core mechanisms underlying mood disorders and how treatment early in life can pave the path to more adaptive outcomes.
 
In her spare time, Dr. Singh enjoys traveling and hiking with her husband and three children, and avidly teaches Indian classical music. 

Learning objectives: 

1. Apply knowledge of how mood symptoms commonly present in youth, including historical perspectives and current state of neuroscience.
2. Utilize current neuroscience knowledge to guide us toward developing better evaluation and treatment strategies for pediatric mood disorders.
3. Integrate knowledge from prior intervention studies (including known placebo effects) to design new clinical trials.